Percutaneous coronary intervention, comorbidities, and mortality among emergency department-admitted ST-elevation

Elizabeth Barnett Pathak1, Joel A Strom

  • 1Department of Epidemiology and Biostatistics, University of South Florida, Tampa, Florida 33612, USA. epathak@health.usf.edu

Insights

Prompt percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) significantly reduces mortality risk. Same-day PCI demonstrated a strong protective effect, lowering in-hospital deaths and supporting guideline recommendations.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition with high mortality risk.
  • Prompt percutaneous coronary intervention (PCI) is the guideline-recommended treatment for STEMI.
  • This study investigates same-day PCI's impact on in-hospital mortality using surveillance data.

Purpose of the Study:

  • To determine if same-day PCI is an independent predictor of in-hospital mortality in STEMI patients.
  • To analyze the association between timely PCI and survival outcomes.
  • To evaluate the influence of patient factors and hospital characteristics on STEMI mortality.

Main Methods:

  • Analysis of hospital discharge data for 43,849 adult STEMI patients admitted via emergency departments (2001-2005).
  • Utilized hierarchical (multilevel) logistic regression models for statistical analysis.
  • Adjusted for comorbidities, patient factors, and hospital PCI volume.

Main Results:

  • In-hospital mortality was 9.4% overall (4,143 deaths).
  • Same-day PCI patients had significantly lower mortality (1.9%) compared to those without (13.0%).
  • Same-day PCI was a strong predictor of survival (adjusted OR = 0.35), with hospital volume not significantly impacting risk.

Conclusions:

  • Same-day PCI significantly reduces in-hospital mortality risk for STEMI patients.
  • Comorbidities, older age, and female gender remain independent predictors of mortality.
  • Findings support national guidelines advocating for aggressive, timely STEMI treatment.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...